Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

The eIF3 interactome reveals the translasome, a supercomplex linking protein synthesis and degradation machineries.

Molecular cell | Oct 9, 2009

http://www.ncbi.nlm.nih.gov/pubmed/19818717

eIF3 promotes translation initiation, but relatively little is known about its full range of activities in the cell. Here, we employed affinity purification and highly sensitive LC-MS/MS to decipher the fission yeast eIF3 interactome, which was found to contain 230 proteins. eIF3 assembles into a large supercomplex, the translasome, which contains elongation factors, tRNA synthetases, 40S and 60S ribosomal proteins, chaperones, and the proteasome. eIF3 also associates with ribosome biogenesis factors and the importins-beta Kap123p and Sal3p. Our genetic data indicated that the binding to both importins-beta is essential for cell growth, and photobleaching experiments revealed a critical role for Sal3p in the nuclear import of one of the translasome constituents, the proteasome. Our data reveal the breadth of the eIF3 interactome and suggest that factors involved in translation initiation, ribosome biogenesis, translation elongation, quality control, and transport are physically linked to facilitate efficient protein synthesis.

Pubmed ID: 19818717 RIS Download

Mesh terms: Actin Cytoskeleton | Active Transport, Cell Nucleus | Enzymes | Eukaryotic Initiation Factor-3 | Models, Molecular | Multiprotein Complexes | Proteasome Endopeptidase Complex | Protein Biosynthesis | Protein Interaction Mapping | Ribosome Subunits | Schizosaccharomyces | Schizosaccharomyces pombe Proteins | Tandem Mass Spectrometry | beta Karyopherins

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: NCI NIH HHS, Id: 5 P30 CA30199-28
  • Agency: NINDS NIH HHS, Id: 5 P30 NS057096
  • Agency: NCI NIH HHS, Id: CA107187
  • Agency: NCI NIH HHS, Id: CA90464
  • Agency: NIGMS NIH HHS, Id: GM059780
  • Agency: NCI NIH HHS, Id: R01 CA090464
  • Agency: NCI NIH HHS, Id: R01 CA090464-04S2
  • Agency: NCI NIH HHS, Id: R01 CA090464-07
  • Agency: NIGMS NIH HHS, Id: R01 GM059780
  • Agency: NIGMS NIH HHS, Id: R01 GM059780-06
  • Agency: NIGMS NIH HHS, Id: R01 GM059780-07
  • Agency: NIGMS NIH HHS, Id: R01 GM059780-08
  • Agency: NIGMS NIH HHS, Id: R01 GM059780-09
  • Agency: NIGMS NIH HHS, Id: R01 GM059780-10A1

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.